$1.56
▼ -6.6% Today
as of Oct 22, 16:48 ET
Last 30 days
Recent Press Releases & News
Femasys Partners with SandsRx Pharmacy to Support FemaSeed® Fertility Portfolio Launch to OB/GYNs
Femasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control
Femasys to Showcase FemaSeed Fertility Treatment at ASRM 2026 as Commercialization Strategy Expands
FEMY earnings at a glance
Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±2.6% on average; after the most recent report on May 8, 2026 it moved -4.2%. FEMY beat the consensus EPS estimate in 1 of its last 2 reported quarters. The share price of $1.56 sits near its 52-week low.
Overview
52-week range
$1.46
$22
0% of range
Avg surprise (last 2)
-12.1%
Avg reaction (last 2)
-1.7%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-1.33 | — | — | — | — | financials |
| Fri May 8, 2026 | Mar/2026 | — | — | — | +100.0% | -4.2% | earnings |
| Fri Nov 14, 2025 | Sep/2025 | $-0.10 | — | — | — | — | earnings |
| Fri Aug 8, 2025 | Jun/2025 | $-0.16 | $-0.18 | +11.1% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.23 | $-0.17 | -35.3% | — | +0.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.24 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.21 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.17 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.26 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.22 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.25 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $331,827 | $424,889 | — | $729,394 | $409,268 | $341,264 | — | $554,908 |
| Cost of revenue | $142,436 | $158,606 | — | $293,838 | $158,171 | $117,266 | — | $190,839 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-5M | $-4M | — | $-4M | $-4M | $-5M | — | $-5M |
| Net income | $-4M | $846,100 | — | $-4M | $-5M | $-6M | — | $-5M |
| EPS (diluted) | $-1.33 | — | — | $-0.10 | $-3.18 | $-0.23 | — | $-0.24 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1M | $5M | $9M | $5M | $3M | $4M | $3M | $8M |
| Inventory | $6M | $6M | $6M | $6M | $5M | $4M | $3M | $2M |
| Total current assets | $8M | $12M | $16M | $12M | $10M | $9M | $8M | $11M |
| Total assets | $12M | $16M | $21M | $16M | $14M | $13M | $12M | $16M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $8M | $9M | $15M | $12M | $12M | $11M | $10M | $10M |
| Total equity | $4M | $7M | $6M | $5M | $2M | $2M | $2M | $6M |
Implied volatility — last 90 days
No IV snapshots yet for FEMY.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
FEMY earnings FAQ
How does FEMY stock usually react to earnings?
Across the last 2 reports the average next-day move was ±2.6%, up 1 times and down 1 times.